Addus HomeCare (NASDAQ:ADUS) Stock Rating Reaffirmed by Royal Bank of Canada

Addus HomeCare (NASDAQ:ADUS)‘s stock had its “outperform” rating reissued by stock analysts at Royal Bank of Canada in a research note issued to investors on Tuesday, Benzinga reports. They currently have a $141.00 target price on the stock. Royal Bank of Canada’s price objective would suggest a potential upside of 7.35% from the company’s previous close.

Several other equities analysts have also recently commented on the stock. Bank of America lifted their target price on shares of Addus HomeCare from $115.00 to $118.00 and gave the stock a “buy” rating in a research report on Tuesday, May 7th. TD Cowen boosted their price objective on Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. StockNews.com lowered Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 7th. Oppenheimer boosted their price target on shares of Addus HomeCare from $130.00 to $140.00 and gave the stock an “outperform” rating in a report on Wednesday, August 7th. Finally, Macquarie initiated coverage on shares of Addus HomeCare in a research note on Friday, June 28th. They set an “outperform” rating and a $136.00 price target for the company. One analyst has rated the stock with a sell rating and eight have assigned a buy rating to the company. Based on data from MarketBeat.com, Addus HomeCare presently has a consensus rating of “Moderate Buy” and an average target price of $127.57.

Addus HomeCare Stock Performance

Shares of NASDAQ ADUS traded down $1.66 during midday trading on Tuesday, hitting $131.35. 12,649 shares of the stock traded hands, compared to its average volume of 134,452. Addus HomeCare has a one year low of $78.35 and a one year high of $134.78. The business has a 50 day moving average price of $123.72 and a two-hundred day moving average price of $110.63. The company has a market cap of $2.38 billion, a PE ratio of 32.59, a P/E/G ratio of 2.43 and a beta of 1.01.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, topping analysts’ consensus estimates of $1.21 by $0.14. The company had revenue of $286.90 million for the quarter, compared to analyst estimates of $284.90 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The firm’s revenue was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.94 EPS. As a group, equities research analysts forecast that Addus HomeCare will post 4.53 EPS for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Roberton James Stevenson sold 217 shares of Addus HomeCare stock in a transaction dated Monday, June 17th. The stock was sold at an average price of $116.13, for a total transaction of $25,200.21. Following the completion of the sale, the executive vice president now owns 10,217 shares of the company’s stock, valued at $1,186,500.21. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other Addus HomeCare news, EVP Roberton James Stevenson sold 217 shares of the business’s stock in a transaction on Monday, June 17th. The shares were sold at an average price of $116.13, for a total value of $25,200.21. Following the completion of the sale, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,186,500.21. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now directly owns 7,215 shares in the company, valued at $961,687.35. The disclosure for this sale can be found here. 4.60% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Addus HomeCare

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. lifted its position in Addus HomeCare by 1.5% during the 1st quarter. Vanguard Group Inc. now owns 1,276,467 shares of the company’s stock valued at $131,910,000 after acquiring an additional 19,027 shares during the period. Wellington Management Group LLP grew its stake in shares of Addus HomeCare by 1.2% in the 4th quarter. Wellington Management Group LLP now owns 798,435 shares of the company’s stock worth $74,135,000 after buying an additional 9,548 shares during the last quarter. Point72 Asset Management L.P. raised its stake in Addus HomeCare by 73.4% during the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after buying an additional 315,602 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Addus HomeCare by 0.8% in the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after acquiring an additional 5,421 shares in the last quarter. Finally, Principal Financial Group Inc. increased its holdings in shares of Addus HomeCare by 20.9% during the second quarter. Principal Financial Group Inc. now owns 430,444 shares of the company’s stock valued at $49,979,000 after acquiring an additional 74,488 shares in the last quarter. Institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.